Diabetes is a common cause of chronic kidney disease (CKD), but in aggregate, non-
diabetic diseases account for a higher proportion of cases of CKD than diabetes in many …

Chronic kidney disease (CKD) is prevalent in many countries, and the costs associated with
the care of patients with end-stage renal disease (ESRD) are estimated to exceed US $1 …

Background The effects of the sodium-glucose co-transporter 2 inhibitor empagliflozin on
renal and cardiovascular disease have not been tested in a dedicated population of people …

Rationale & Objective Chronic kidney disease (CKD) is a global health problem with
increasing prevalence. Several sex-specific differences have been reported for disease …

Introduction Chronic kidney disease (CKD) is an important noncommunicable disease
globally. Overall prevalence of CKD and distribution of its stages differ between countries …

Chronic kidney disease (CKD), defined as the presence of albuminuria and/or reduction in
estimated glomerular filtration rate (eGFR)< 60 mL/min/1.73 m2, is considered a growing …

Background Annual decline in kidney function is a widely applied surrogate outcome of
renal failure. It is important to understand the relationships between known risk factors and …

Primary kidney disease is suggested to affect renal prognosis of CKD patients; however,
whether nephrology care modifies this association is unknown. We studied patients with …

Background: The risk of renal damage in patients with high alcohol consumption is
controversial. The objective of this meta-analysis was to evaluate the associations between …

Chronic kidney disease (CKD) is a major healthcare challenge, affecting> 800 million
people worldwide. Implications for population health result from the strong associations of …